|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07D 213/81 | (2006.01) |
| A61K 31/4418 | (2006.01) | ||
| A61P 35/00 | (2006.01) |
| (11) | Number of the document | 3357911 |
| (13) | Kind of document | T |
| (96) | European patent application number | 18158907.8 |
| Date of filing the European patent application | 2007-06-26 | |
| (97) | Date of publication of the European application | 2018-08-08 |
| (45) | Date of publication and mention of the grant of the patent | 2022-05-11 |
| (46) | Date of publication of the claims translation | 2022-08-10 |
| (30) | Number | Date | Country code |
| 816522 P | 2006-06-26 | US |
| (72) |
Kawamoto, Richard Masaru , US
Warshakoon, Namal, Chithranga , US
Wu, Shengde , US
Boyer, Angelique, Sun , US
Greis, Kenneth, Donald , US
|
| (73) |
Akebia Therapeutics Inc. ,
245 First Street, Suite 1100, Cambridge, MA 02142,
US
|
| (74) |
Aušra PAKĖNIENĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Prolilo hidroksilazės inhibitoriai ir naudojimo būdai |
| PROLYL HYDROXYLASE INHIBITORS AND METHODS OF USE |
| Payment date | Validity (years) | Amount | |
| 2025-05-22 | 19 | 347.00 EUR |
| 2026-06-26 |